Capta Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Delhi, Delhi, India, established in 2014.
2014 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Capta Pharmaceuticals Private Limited

Capta Pharmaceuticals Private Limited, a struck off private limited company, was established on 18 July 2014 in Delhi, Delhi, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100DL2014PTC269076. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pallavi (Director), Manju Bala (Director), Kuldip Kumar Sekhri (Director). It is based at Shop No 1, Ground Floor(21/2) Blk 21, Moti Nagar, Near Arya Samaj Mand, Ir, Delhi, Delhi, 110015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2014PTC269076

  • Registration Number

    269076

  • Incorporation Date

    18 July 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 10 Months
Company report

Capta Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Capta Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Capta Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pallavi Director 18 Jul 2014 Current
Manju Bala Director 18 Jul 2014 Current
Kuldip Kumar Sekhri Director 18 Jul 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Capta Pharmaceuticals.

Enhance accessibility to Capta Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Capta Pharmaceuticals revenue growth over time
Capta Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Capta Pharmaceuticals?

Unlock access to Capta Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Capta Pharmaceuticals?

Unlock and access historical data on people associated with Capta Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Capta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Capta Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Capta Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Pallavi was appointed as a Director was appointed as a Director on 18 Jul 2014 & has been associated with this company since 11 years 10 months . was documented.

  • Director Appointment

    Progress on Manju Bala was appointed as a Director was appointed as a Director on 18 Jul 2014 & has been associated with this company since 11 years 10 months . was documented.

  • Director Appointment

    Progress on Kuldip Kumar Sekhri was appointed as a Director was appointed as a Director on 18 Jul 2014 & has been associated with this company since 11 years 10 months . was documented.

  • Company Incorporation

    Progress on Capta Pharmaceuticals Private Limited was registered on 18 Jul 2014 with Roc Delhi & aged 11 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Capta Pharmaceuticals Private Limited?

The CIN of Capta Pharmaceuticals Private Limited is U24100DL2014PTC269076.

Where is Capta Pharmaceuticals Private Limited headquartered?

Capta Pharmaceuticals Private Limited is headquartered at Shop No 1, Ground Floor(21/2) Blk 21, Moti Nagar, Near Arya Samaj Mand, Ir, Delhi, Delhi, 110015.

When was Capta Pharmaceuticals Private Limited incorporated?

Capta Pharmaceuticals Private Limited was incorporated on 18 July 2014.

Who are the current directors of Capta Pharmaceuticals Private Limited?

The current directors of Capta Pharmaceuticals Private Limited are

What is the primary industry of Capta Pharmaceuticals Private Limited?

The primary industry of Capta Pharmaceuticals Private Limited is Chemicals.

Is Capta Pharmaceuticals Private Limited a listed company?

Capta Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Capta Pharmaceuticals Private Limited?

The authorized capital of Capta Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available